Abstract Details

Title Height and Race Predict the Rate of Regeneration in a Double Blind, Placebo Controlled Trial of the Neurophilin Timcodar Dimesylate

Topic Anterior Horn and Peripheral Nerve

Presentation(s) (-)

Poster/Presentation
Number 133

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Carolina VIVAR, MD	Dr. VIVAR has nothing to disclose.
Cynthia L. Harden, MD (Xenon Pharmaceuticals Inc)	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
J. David Avila, MD, FAAN (Geisinger Medical Center)	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Jay Salpekar	No disclosure on file
Hoda Abdel-Hamid, MD, FAAN (UPMC Children'S Hospital of Pittsburgh)	No disclosure on file
	No disclosure on file

��ɫ��